PT4136091T - Formas e composições de inibidores da calicreína plasmática - Google Patents

Formas e composições de inibidores da calicreína plasmática

Info

Publication number
PT4136091T
PT4136091T PT217244300T PT21724430T PT4136091T PT 4136091 T PT4136091 T PT 4136091T PT 217244300 T PT217244300 T PT 217244300T PT 21724430 T PT21724430 T PT 21724430T PT 4136091 T PT4136091 T PT 4136091T
Authority
PT
Portugal
Prior art keywords
inhibitors
compositions
forms
plasma kallikrein
kallikrein
Prior art date
Application number
PT217244300T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of PT4136091T publication Critical patent/PT4136091T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/06—Oxalic acid
    • C07C55/07—Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/10—Succinic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT217244300T 2020-04-17 2021-04-16 Formas e composições de inibidores da calicreína plasmática PT4136091T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063011776P 2020-04-17 2020-04-17

Publications (1)

Publication Number Publication Date
PT4136091T true PT4136091T (pt) 2025-08-22

Family

ID=75870731

Family Applications (1)

Application Number Title Priority Date Filing Date
PT217244300T PT4136091T (pt) 2020-04-17 2021-04-16 Formas e composições de inibidores da calicreína plasmática

Country Status (9)

Country Link
US (1) US20230167132A1 (enExample)
EP (2) EP4136091B1 (enExample)
JP (2) JP2023522331A (enExample)
DK (1) DK4136091T3 (enExample)
ES (1) ES3035604T3 (enExample)
FI (1) FI4136091T3 (enExample)
PL (1) PL4136091T3 (enExample)
PT (1) PT4136091T (enExample)
WO (1) WO2021211930A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4494698A3 (en) * 2017-08-04 2025-04-23 Takeda Pharmaceutical Company Limited Inhibitors of plasma kallikrein and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
JP5069905B2 (ja) * 2003-01-21 2012-11-07 アプテュイト （ウエスト ラファイエット）、エルエルシー 新規な共結晶化
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
PT3650439T (pt) * 2010-07-23 2021-03-03 Gruenenthal Gmbh Sais ou cocristais de 3-(3-dimetilamino-1-etil-2-metilpropil)fenol
EP2663647A4 (en) * 2011-01-14 2015-08-19 Redwood Bioscience Inc POLYPEPTIDE IMMUNOGLOBULINS WITH ALDEHYDIC MARKING AND THEIR USE METHOD
CN112135825A (zh) * 2018-03-13 2020-12-25 夏尔人类遗传性治疗公司 血浆激肽释放酶抑制剂及其用途

Also Published As

Publication number Publication date
JP2025142238A (ja) 2025-09-30
FI4136091T3 (fi) 2025-07-25
DK4136091T3 (da) 2025-08-18
PL4136091T3 (pl) 2025-08-18
US20230167132A1 (en) 2023-06-01
EP4136091B1 (en) 2025-05-28
WO2021211930A1 (en) 2021-10-21
EP4623913A3 (en) 2025-12-24
ES3035604T3 (en) 2025-09-05
JP2023522331A (ja) 2023-05-30
WO2021211930A8 (en) 2021-12-16
EP4623913A2 (en) 2025-10-01
EP4136091A1 (en) 2023-02-22

Similar Documents

Publication Publication Date Title
PT4031547T (pt) Inibidores de calicreína plasmática e utilizações dos mesmos
IL321357A (en) KIF18A inhibitors and their uses
IL318169A (en) Apol1 inhibitors and methods of use are the same
EP4076395A4 (en) INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CGRP INHIBITORS
IL320739A (en) rock2 inhibitors
EP4448514A4 (en) TYK2 INHIBITORS AND ASSOCIATED COMPOSITIONS AND PROCESSES
IL316616A (en) ROCK2 inhibitors
SG11202102479TA (en) Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
CA3264917A1 (en) KIF18A INHIBITORS AND THEIR USES
IL318607A (en) Plasma kallikrein inhibitors
IL316435A (en) Plasma kallikrein inhibitor formulations
IL289214A (en) Crystalline forms of plasma kallikrein inhibitors
EP4376846A4 (en) BIOACTIVE COMPOSITIONS AND METHODS OF USE THEREOF
EP4164634A4 (en) PLASMAKALLIK INHIBITORS
IL319844A (en) Compounds and compositions useful as IAPS inhibitors
PL4136091T3 (pl) Postacie i kompozycje inhibitorów kalikreiny osoczowej
EP4119164A4 (en) ANTI-CORONAVIRUS EFFECT AND APPLICATION OF PI4K INHIBITOR
IL327134A (en) Topical formulations and uses of PAI-1 inhibitors
HK40089013A (zh) 血浆激肽释放酶抑制剂的形式和组合物
IL314164A (en) Inhibitors of complement factors and their uses
HK40106193A (en) Inhibitors of plasma kallikrein
AU2024371427A1 (en) Compositions and inhibitors of polrmt
CA3310097A1 (en) Compositions and inhibitors of polrmt
HK40106238A (en) Imidazopyridinyl inhibitors of plasma kallikrein
HK40107438A (en) Polycyclic inhibitors of plasma kallikrein